Key facts
- Hurone AI’s last known valuation is $11.0M (Feb 2025).
- It has raised $1.1M; the latest was Seed Round ($1.0M) in Feb 2025.
- Notable investors include ODBA.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Hurone AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Hurone AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hurone AI
Developer of an AI (artificial intelligence)-native oncology navigation platform designed to support cancer patients through treatment guidance, social needs assistance, and streamlined care coordination within value-based care models. The company offers AI-driven navigation, integrated treatment support, and coordinated patient-management capabilities, enabling cancer care teams and health systems to reduce workflow burden and improve outcomes.
- Sector
- Healthcare
- HQ
- Seattle, WA, United States
- Founded
- 2021
- Employees
- 10
- Website
- hurone.ai/
- Ownership
- Privately Held (backing)
Hurone AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hurone AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hurone AI in its N-PORT filings yet. We sweep new filings monthly.